Telix Pharmaceuticals
FDA Allowing Compassionate Use Access to Telix's Glioma PET Imaging Agent
Telix will seek FDA approval to sell TLX101-CDx as an imaging agent for advanced glioma patients.
Telix Files for FDA Approval for New PSMA-PET Imaging Agent TLX007-CDx
The firm already markets a radiopharmaceutical companion diagnostic for Pluvicto but is hoping to improve patient access with this new imaging agent.
In Brief This Week: Deep Bio, Landmark Bio, Telix Pharmaceuticals, The Max Foundation, Roche
News items for the week of Nov. 6, 2023.
In Brief This Week: Kyverna Therapeutics, LianBio, Orgenesis, Telix Pharmaceuticals
News items for the week of June 5, 2023.